טוען...
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
After decades of clinical and basic science research, the clinical application of botulinum toxin A (Botox) in urology has been extended to neurogenic detrusor overactivity (NDO), idiopathic detrusor overactivity, refractory overactive bladder (OAB), interstitial cystitis/bladder pain syndrome (IC/B...
שמור ב:
| הוצא לאור ב: | Investig Clin Urol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Urological Association
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004832/ https://ncbi.nlm.nih.gov/pubmed/32055752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2020.61.S1.S33 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|